ConductScience.org, home

Paper2494640

Long-term tobramycin aerosol therapy in cystic fibrosis.

Steinkamp G and 6 others. Pediatr Pulmonol, 1989. Cited by 123 papers, by iCite.

Cite this record

ConductScience Library. Long-term tobramycin aerosol therapy in cystic fibrosis. Papers, record 2494640. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2494640

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Long-term tobramycin aerosol therapy in cystic fibrosis.
PubMed
Journal
Pediatr Pulmonol
PubMed
Year
1989
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
123
iCite
Relative citation ratio, by iCite
5.25
iCite
Revised in PubMed
2019-09-12
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Steinkamp GG
2Tümmler BB
3Gappa MM
4Albus AA
5Potel JJ
6Döring GG
7von der Hardt HH

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Cystic FibrosisMajor topic
Pseudomonas InfectionsMajor topic
Respiratory Tract InfectionsMajor topic
TobramycinMajor topic
Administration, Inhalation
Adolescent
Aerosols
Child
Drug Resistance, Microbial
Humans
Pseudomonas aeruginosa
Time Factors

Source PubMed

Download CSV of topics

Cited by28

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 123 citations.

PMIDTitleJournalYearIn PapersSource
36373968Inhaled anti-pseudomonal antibiotics for long-term therapy in cystic fibrosis.Cochrane Database Syst Rev2022https://conductscience.org/library/papers/36373968PubMed
33255354Impact of Pseudomonas aeruginosa Infection on Patients with Chronic Inflammatory Airway Diseases.J Clin Med2020https://conductscience.org/library/papers/33255354PubMed
31112621Pharmacokinetics and safety of tobramycin nebulization with the I-neb and PARI-LC Plus in children with cystic fibrosis: A randomized, crossover study.Br J Clin Pharmacol2019https://conductscience.org/library/papers/31112621PubMed
29904366Bilateral Vestibular Weakness.Front Neurol2018https://conductscience.org/library/papers/29904366PubMed
29607494Inhaled anti-pseudomonal antibiotics for long-term therapy in cystic fibrosis.Cochrane Database Syst Rev2018https://conductscience.org/library/papers/29607494PubMed
26959239Tolerability and Pharmacokinetic Evaluation of Inhaled Dry Powder Tobramycin Free Base in Non-Cystic Fibrosis Bronchiectasis Patients.PLoS One2016https://conductscience.org/library/papers/26959239PubMed
26573178Management of Pseudomonas aeruginosa infection in cystic fibrosis patients using inhaled antibiotics with a focus on nebulized liposomal amikacin.Future Microbiol2015https://conductscience.org/library/papers/26573178PubMed
21233507Clinical significance of microbial infection and adaptation in cystic fibrosis.Clin Microbiol Rev2011https://conductscience.org/library/papers/21233507PubMed
20692633Early eradication of Pseudomonas aeruginosa in patients with cystic fibrosis.Paediatr Respir Rev2010https://conductscience.org/library/papers/20692633PubMed
20191398Inhaled anti-infective agents: emphasis on colistin.Infection2010https://conductscience.org/library/papers/20191398PubMed
19538104Inhaled therapeutics for prevention and treatment of pneumonia.Expert Opin Drug Saf2009https://conductscience.org/library/papers/19538104PubMed
14609360Inhaled tobramycin (TOBI): a review of its use in the management of Pseudomonas aeruginosa infections in patients with cystic fibrosis.Drugs2003https://conductscience.org/library/papers/14609360PubMed
12096202Relationship between nutritional status and lung function in cystic fibrosis: cross sectional and longitudinal analyses from the German CF quality assurance (CFQA) project.Thorax2002https://conductscience.org/library/papers/12096202PubMed
12083973Nebulized antibiotics in cystic fibrosis.Paediatr Drugs2002https://conductscience.org/library/papers/12083973PubMed
11706924Commonly used antibacterial and antifungal agents for hospitalised paediatric patients: implications for therapy with an emphasis on clinical pharmacokinetics.Paediatr Drugs2001https://conductscience.org/library/papers/11706924PubMed
11598071Dual-function vaccine for Pseudomonas aeruginosa: characterization of chimeric exotoxin A-pilin protein.Infect Immun2001https://conductscience.org/library/papers/11598071PubMed
10319054Long-term follow up of changes in FEV1 and treatment intensity during Pseudomonas aeruginosa colonisation in patients with cystic fibrosis.Thorax1998https://conductscience.org/library/papers/10319054PubMed
10086932Is prolonged rotavirus infection a common cause of protracted diarrhoea?Arch Dis Child1999https://conductscience.org/library/papers/10086932PubMed
10086931Evidence for using nebulised antibiotics in cystic fibrosis.Arch Dis Child1999https://conductscience.org/library/papers/10086931PubMed
9713010Urinary N-acetyl-beta-D-glucosaminidase activity in patients with cystic fibrosis on long-term gentamicin inhalation.Arch Dis Child1998https://conductscience.org/library/papers/9713010PubMed

See all 28 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/2494640

GET https://conductscience.org/api/papers/v1/2494640/cited_by?page=2